Participant characteristics
colorectal cancer
COLORECTAL CANCER, RECRUITMENT
Data for this trial was collected between November 2019 and February 2021. The target sample size was 30 evaluable participants; however, the trial was ended prematurely due to the impact of the COVID-19 pandemic on recruitment. A total of seven evaluable participants completed the trial (n = 2 in HIIT, n = 5 in MICE). A participant was considered evaluable if he/she completed baseline and EOS assessments. Median age of participants was 39 years (1st quartile: 36, 3rd quartile: 50), and median BMI was 27.4 kg/m2 (1st quartile: 24.5, 3rd quartile: 29.7). Most participants were diagnosed with stage III colorectal cancer (71%, 